Product GroupsProduct Groups

Name:	Galanthamine Hydrobromide
Formula:	C17H21NO3
CAS:	1953-04-4

Therapeutic use:	treatment of Alzheimer's disease
Final dosage form types:	tablets, injections
Specification:	internal
Available Documents:	DMF